These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7551241)

  • 1. Cytokines as immunological adjuvants.
    Heath AW
    Pharm Biotechnol; 1995; 6():645-58. PubMed ID: 7551241
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytokines as immunological adjuvants.
    Heath AW; Playfair JH
    Vaccine; 1992; 10(7):427-34. PubMed ID: 1609545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines as vaccine adjuvants. Current status and potential applications.
    Dong P; Brunn C; Ho RJ
    Pharm Biotechnol; 1995; 6():625-43. PubMed ID: 7551240
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytokines as natural adjuvants for vaccines: where are we now?
    Rizza P; Ferrantini M; Capone I; Belardelli F
    Trends Immunol; 2002 Aug; 23(8):381-3. PubMed ID: 12133794
    [No Abstract]   [Full Text] [Related]  

  • 5. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases.
    Lin R; Tarr PE; Jones TC
    Clin Infect Dis; 1995 Dec; 21(6):1439-49. PubMed ID: 8749629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-containing liposomes as adjuvants for subunit vaccines.
    Lachman LB; Shih LC; Rao XM; Ullrich SE; Cleland JL
    Pharm Biotechnol; 1995; 6():659-71. PubMed ID: 7551242
    [No Abstract]   [Full Text] [Related]  

  • 7. The adjuvant potential of cytokines.
    Hughes HP; Babiuk LA
    Biotechnol Ther; 1992; 3(3-4):101-17. PubMed ID: 1303725
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical applications of cytokines for immunostimulation and immunosuppression.
    Lee B; Ciardelli TL
    Prog Drug Res; 1992; 39():167-96. PubMed ID: 1475362
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant activity of cytokines.
    Tovey MG; Lallemand C
    Methods Mol Biol; 2010; 626():287-309. PubMed ID: 20099135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine-containing liposomes as vaccine adjuvants.
    Lachman LB; Ozpolat B; Rao XM
    Eur Cytokine Netw; 1996 Dec; 7(4):693-8. PubMed ID: 9010671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal cytokines and liposomes targeted to costimulatory molecules as adjuvants for human immunodeficiency virus subunit vaccines.
    Ozpolat B; Lachman LB
    Methods Enzymol; 2003; 373():92-100. PubMed ID: 14714398
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological adjuvants and their mode of action.
    Allison AC; Byars NE
    Biotechnology; 1992; 20():431-49. PubMed ID: 1600387
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of mucosal IgA responses in vivo: cytokines and adjuvants.
    Husband AJ; Kramer DR; Bao S; Sutherland RM; Beagley KW
    Vet Immunol Immunopathol; 1996 Nov; 54(1-4):179-86. PubMed ID: 8988863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulating peptides of natural and synthetic origin.
    St Georgiev V
    Med Res Rev; 1991 Jan; 11(1):81-119. PubMed ID: 1994154
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effectiveness of ultrasmall doses of endogenous bioregulators and immunoactive compounds].
    Ashmarin IP; Karazeeva EP; Lelekova TV
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):109-16. PubMed ID: 16028533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between birth order and immunological parameters?
    Bernsen RM; al-Ramadi BK
    Placenta; 2011 Nov; 32(11):922. PubMed ID: 21641032
    [No Abstract]   [Full Text] [Related]  

  • 17. [An analysis of current trends in the creation of immunotropic agents].
    Uteshev BS; Sergeev AS; Korostelev SA
    Eksp Klin Farmakol; 1995; 58(3):3-7. PubMed ID: 7663291
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytokines as adjuvants: effect on the immunogenicity of NeuAc alpha 2-6GalNAc alpha-O-Ser/Thr (sialyl-Tn).
    Piera M; de Bolós C; Castro R; Real FX
    Int J Cancer; 1993 Aug; 55(1):148-52. PubMed ID: 8344745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of leukinferon immunocorrection in patients with maxillofacial phlegmons].
    Tsymbalov OV; Nedel'ko NA; Kuznetsov VP; Beliaev DL
    Stomatologiia (Mosk); 2003; 82(6):23-6. PubMed ID: 14671589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory cytokines.
    Opal SM; DePalo VA
    Chest; 2000 Apr; 117(4):1162-72. PubMed ID: 10767254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.